H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
2025 · 1st Quarter (Jan 1 - Mar 31)
AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC.
Filed by S-3 GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2025
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- S-3 GROUP
- Filing UUID
- e05e5bbc-f9ce-49d2-bdd6-0e3da7d00270
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to health care research in FY26 Labor Health and Human Services Subcommittee
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.